Vienna Institute For Research In Ocular Surgery
Clinical trials sponsored by Vienna Institute For Research In Ocular Surgery, explained in plain language.
-
Can a higher dose of eylea help wet AMD patients go longer between eye injections?
Disease control OngoingThis study looks at whether switching to a higher dose (8mg) of the drug Aflibercept can help people with wet age-related macular degeneration (AMD) who are not responding well to the standard 2mg dose. The goal is to see if the stronger dose allows for fewer eye injections while…
Sponsor: Vienna Institute for Research in Ocular Surgery • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
Diabetes drug metformin may slow cataract cell growth
Knowledge-focused OngoingThis pilot study looks at 40 adults with type 2 diabetes and age-related cataracts who take metformin. Researchers measure how much metformin reaches the lens capsule and test whether it slows lens cell growth in the lab. The goal is to understand if metformin might help prevent …
Phase: NA • Sponsor: Vienna Institute for Research in Ocular Surgery • Aim: Knowledge-focused
Last updated May 26, 2026 12:04 UTC